LOCALIZED PROSTATE ADENOCARCINOMA
Clinical trials for LOCALIZED PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALIZED PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALIZED PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two shots vs. five: testing a faster prostate cancer treatment
Disease control Recruiting nowThis study is testing if a shorter, more precise form of radiation therapy is as effective as the standard longer course for treating prostate cancer that hasn't spread. Men with localized prostate cancer will be randomly assigned to receive either two treatments of a newer, adap…
Matched conditions: LOCALIZED PROSTATE ADENOCARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Daily radiation Tune-Ups aim to spare men from side effects
Disease control Recruiting nowThis study is testing whether adjusting radiation treatment plans daily using real-time MRI or CT scans can reduce side effects for men with localized prostate cancer. Researchers will compare this 'adaptive' approach to standard radiation that uses a fixed plan. The goal is to s…
Matched conditions: LOCALIZED PROSTATE ADENOCARCINOMA
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Radiation breakthrough aims to spare men from treatment side effects
Disease control Recruiting nowThis study is testing a more precise form of radiation therapy for prostate cancer that hasn't spread. It uses real-time imaging to track the prostate's movement during treatment, allowing doctors to deliver radiation more accurately. The goal is to reduce common side effects lik…
Matched conditions: LOCALIZED PROSTATE ADENOCARCINOMA
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC